登录

Chapter 19

Lower Respiratory Disorders

哮喘的发病机制和管理
哮喘的发病机制和管理
Asthma, a chronic respiratory condition, entails airway inflammation, hyper-reactivity, and reversible obstruction of the airways. It is categorized as ...
抗哮喘药物: β<sub>2</sub>-肾上腺素能受体激动剂
抗哮喘药物: β2-肾上腺素能受体激动剂
Bronchodilators play a pivotal role in asthma management. They ease airway constriction by relaxing bronchial muscles. One class of bronchodilators ...
抗哮喘药物: 甲基黄嘌呤
抗哮喘药物: 甲基黄嘌呤
Methylxanthines, such as theophylline, act as bronchodilators to manage asthma. Theophylline's exact mechanism of action is complex, potentially ...
抗哮喘药物: 白三烯调节剂
抗哮喘药物: 白三烯调节剂
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, effectively manage chronic asthma by targeting inflammatory mediators produced ...
抗哮喘药物: 毒蕈碱受体拮抗剂
抗哮喘药物: 毒蕈碱受体拮抗剂
Muscarinic receptor antagonists, or antimuscarinic agents, are a class of bronchodilators used for asthma treatment. They inhibit the action of ...
抗哮喘药物:吸入性皮质类固醇和糖皮质激素
抗哮喘药物:吸入性皮质类固醇和糖皮质激素
Inhaled corticosteroids, or ICS, are potent anti-inflammatory drugs pivotal in asthma management. They precisely target the bronchial mucosa to control ...
抗哮喘药物:肥大细胞稳定剂和抗 IgE 药物
抗哮喘药物:肥大细胞稳定剂和抗 IgE 药物
Anti-inflammatory drugs such as mast cell stabilizers and anti-IgE drugs play a crucial role in asthma management. Mast cell stabilizers, such as ...
COPD 的发病机制和临床特征
COPD 的发病机制和临床特征
COPD, short for chronic obstructive pulmonary disease, is a progressive lung disease that primarily affects the airways, leading to the gradual loss of ...
COPD: 使用支气管扩张剂和皮质类固醇进行治疗
COPD: 使用支气管扩张剂和皮质类固醇进行治疗
Chronic obstructive pulmonary disease, or COPD, encompasses progressive lung conditions, including chronic bronchitis, emphysema, and asthma. Its symptoms ...
JoVE Logo

政策

使用条款

隐私

科研

教育

关于 JoVE

版权所属 © 2025 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。